ROSTRA THERAPEUTICS LTD
Significant control: John Edward Mulgrew (25–50%), James David Gordon Findlay (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Rostra Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ROSTRA THERAPEUTICS LTD is an active private limited company (company number SC724070) incorporated on 22 February 2022, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2025, showing net assets of −£63k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 43% on the prior period (−£44k).
By net assets it sits in the bottom quarter of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
Ownership and control
- Mr John Edward Mulgrew
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr James David Gordon Findlay
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Professor Colin James Suckling
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr James David Gordon Findlay
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr John Edward Mulgrew
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 22 February 20224 yrs ago
- Next accounts due
- 28 November 2026in 36 days
- Confirmation statement due
- 8 March 2027in 136 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£63k | — | — | £41k | — | — | 0 |
| 29 February 2024 | −£44k | — | — | £380 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-63,024 at 28 February 2025
- Net assets down 25% or more on the prior period-43.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.71
- Incorporated two to five years agoIncorporated 22 February 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 136 days
- Next accounts duein 36 days
- Accounts period endNet liabilities £63k · micro accounts
- Accounts period endNet liabilities £44k · micro accounts
- Incorporated
Similar companies in Edinburgh
- BIOMARA LIMITEDEdinburgh · inc. Mar 2022
- TRANSPHARMAC LIMITEDEdinburgh · inc. Apr 2022
- LARIO THERAPEUTICS LIMITEDEdinburgh · inc. Nov 2021
- TARGOPEP LIMITEDEdinburgh · inc. Nov 2021
- MMWR LTDEdinburgh · inc. Jun 2022
- BRAIN HEALTH SCOTLAND LIFE SCIENCES LTDEdinburgh · inc. Jun 2022
All companies incorporated on 22 February 2022 · in Feb 2022.
Reminders for ROSTRA THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.